Oligomeric amyloid-β(1-42) induces THP-1 human monocyte adhesion and maturation

Brain Research

Volumn 1254, Issue , 2009, Pages 109-119

  Crouse, Nikkilina R ^a   Ajit, Deepa ^a   Udan, Maria L D ^a   Nichols, Michael R ^a  

^a UNIVERSITY OF MISSOURI ST LOUIS   (United States)

Author keywords

Adhesion; Alzheimer's disease; Amyloid ; Monocytes; Oligomer

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); CD11B ANTIGEN; DRUG DERIVATIVE; FIBRONECTIN; ITGAM PROTEIN, HUMAN; PEPTIDE FRAGMENT; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOLOL MYRISTATE ACETATE;

ARTICLE; ATOMIC FORCE MICROSCOPY; CELL ADHESION; CELL DIFFERENTIATION; CELL LINE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HUMAN; METABOLISM; MISSENSE MUTATION; MONOCYTE; PHYSIOLOGY; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

AMYLOID BETA-PROTEIN; ANTIGENS, CD11B; CELL ADHESION; CELL DIFFERENTIATION; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRONECTINS; HUMANS; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, TRANSMISSION; MONOCYTES; MUTATION, MISSENSE; PEPTIDE FRAGMENTS; TETRADECANOYLPHORBOL ACETATE;

EID: 58549120413     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.11.093     Document Type: Article

References (47)

1. Auwerx J. The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Experientia 47 (1991) 22-31
2. Bamberger M.E., Harris M.E., McDonald D.R., Husemann J., and Landreth G.E. A cell surface receptor complex for fibrillar β-amyloid mediates microglial activation. J. Neurosci. 23 (2003) 2665-2674
3. Bitan G., Kirkitadze M.D., Lomakin A., Vollers S.S., Benedek G.B., and Teplow D.B. Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 330-335
4. Carson M.J., Bilousova T.V., Puntambekar S.S., Melchior B., Doose J.M., and Ethell I.M. A rose by any other name? The potential consequences of microglial heterogeneity during CNS health and disease. Neurotherapeutics 4 (2007) 571-579
5. Dahlgren K.N., Manelli A.M., Stine Jr. W.B., Baker L.K., Krafft G.A., and LaDu M.J. Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J. Biol. Chem. 277 (2002) 32046-32053
6. Deshpande A., Mina E., Glabe C., and Busciglio J. Different conformations of amyloid β induce neurotoxicity by distinct mechanisms in human cortical neurons. J. Neurosci. 26 (2006) 6011-6018
7. Dickson D.W., Lee S.C., Mattiace L.A., Yen S.H.C., and Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer disease. Glia 7 (1993) 75-83
8. Ding Q., Jin T., Wang Z., and Chen Y. Catalase potentiates retinoic acid-induced THP-1 monocyte differentiation into macrophage through inhibition of peroxisome proliferator-activated receptor γ. J. Leukoc. Biol. 81 (2007) 1568-1576
9. Eglitis M.A., and Mezey E. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 4080-4085
10. El Khoury J., Toft M., Hickman S.E., Means T.K., Terada K., Geula C., and Luster A.D. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 13 (2007) 432-438
11. Fassbender K., Walter S., Kuhl S., Landmann R., Ishii K., Bertsch T., Stalder A.K., Muehlhauser F., Liu Y., Ulmer A.J., Rivest S., Lentschat A., Gulbins E., Jucker M., Staufenbiel M., Brechtel K., Walter J., Multhaup G., Penke B., Adachi Y., Hartmann T., and Beyreuther K. The LPS receptor (CD14) links innate immunity with Alzheimer's disease. FASEB J. 18 (2004) 203-205
12. Fiala M., Zhang L., Gan X., Sherry B., Taub D., Graves M.C., Hama S., Way D., Weinand M., Witte M., Lorton D., Kuo Y.M., and Roher A.E. Amyloid-β induces chemokine secretion and monocyte migration across a human blood-brain barrier model. Mol. Med. 4 (1998) 480-489
13. Giri R., Shen Y.M., Stins M., Yan S.D., Schmidt A.M., Stern D., Kim K.S., Zlokovic B., and Kalra V.K. β-Amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. Am. J. Physiol. Cell Physiol. 279 (2000) C1772-C1781
14. Gravina S.A., Ho L., Eckman C.B., Long K.E., Otvos Jr. L., Younkin L.H., Suzuki N., and Younkin S.G. Amyloid β protein (Aβ) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ40 or Aβ42(43). J. Biol. Chem. 270 (1995) 7013-7016
15. Harper J.D., Wong S.S., Lieber C.M., and Lansbury Jr. P.T. Observation of metastable Aβ amyloid protofibrils by atomic force microscopy. Chem. Biol. 4 (1997) 119-125
16. Harper J.D., Wong S.S., Lieber C.M., and Lansbury Jr. P.T. Assembly of Aβ amyloid peptides: an in vitro model for a possible early event in Alzheimer's disease. Biochemistry 38 (1999) 8972-8980
17. Hepler R.W., Grimm K.M., Nahas D.D., Breese R., Dodson E.C., Acton P., Keller P.M., Yeager M., Wang H., Shughrue P., Kinney G., and Joyce J.G. Solution state characterization of amyloid β-derived diffusible ligands. Biochemistry 45 (2006) 15157-15167
18. Hickstein D.D., Baker D.M., Gollahon K.A., and Back A.L. Identification of the promoter of the myelomonocytic leukocyte integrin CD11b. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 2105-2109
19. Hmama Z., Knutson K.L., Herrera-Velit P., Nandan D., and Reiner N.E. Monocyte adherence induced by lipopolysaccharide involves CD14, LFA-1, and cytohesin-1. Regulation by Rho and phosphatidylinositol 3-kinase. J. Biol. Chem. 274 (1999) 1050-1057
20. Jarrett J.T., and Lansbury Jr. P.T. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?. Cell 73 (1993) 1055-1058
21. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., and Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300 (2003) 486-489
22. Kounalakis N.S., and Corbett S.A. Lipopolysaccharide transiently activates THP-1 cell adhesion. J. Surg. Res. 135 (2006) 137-143
23. 1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 6448-6453
24. 42 activates a G-protein-coupled chemoattractant receptor, FPR-like 1. J. Neurosci. 21 (2001) RC123
25. Lesne S., Koh M.T., Kotilinek L., Kayed R., Glabe C.G., Yang A., Gallagher M., and Ashe K.H. A specific amyloid-β protein assembly in the brain impairs memory. Nature 440 (2006) 352-357
26. Lorenzo A., and Yankner B.A. β-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 12243-12247
27. Maslow K. 2008 Alzheimer's disease facts and figures. Alzheimer's Dement. 4 (2008) 110-133
28. McGeer P.L., Itagaki S., Tago H., and McGeer E.G. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci. Lett. 79 (1987) 195-200
29. Meyer-Luehmann M., Spires-Jones T.L., Prada C., Garcia-Alloza M., de Calignon A., Rozkalne A., Koenigsknecht-Talboo J., Holtzman D.M., Bacskai B.J., and Hyman B.T. Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer's disease. Nature 451 (2008) 720-724
30. Park E.K., Jung H.S., Yang H.I., Yoo M.C., Kim C., and Kim K.S. Optimized THP-1 differentiation is required for the detection of responses to weak stimuli. Inflamm. Res. 56 (2007) 45-50
31. Pike C.J., Walencewicz A.J., Glabe C.G., and Cotman C.W. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563 (1991) 311-314
32. Ruoslahti E., and Pierschbacher M.D. New perspectives in cell adhesion: RGD and integrins. Science 238 (1987) 491-497
33. 3. J. Leukoc. Biol. 59 (1996) 555-561
34. Selkoe D.J. The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8 (1998) 447-453
35. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81 (2001) 741-766
36. Selkoe D.J. Alzheimer disease: mechanistic understanding predicts novel therapies. Ann. Intern. Med. 140 (2004) 627-638
37. Selkoe D.J. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat. Cell Biol. 6 (2004) 1054-1061
38. Simard A.R., Soulet D., Gowing G., Julien J.P., and Rivest S. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49 (2006) 489-502
39. Stine W.B.J., Dahlgren K.N., Krafft G.A., and LaDu M.J. In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis. J. Biol. Chem. 278 (2003) 11612-11622
40. Tsuchiya S., Kobayashi Y., Goto Y., Okumura H., Nakae S., Konno T., and Tada K. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res. 42 (1982) 1530-1536
41. Udan M.L., Ajit D., Crouse N.R., and Nichols M.R. Toll-like receptors 2 and 4 mediate Aβ(1-42) activation of the innate immune response in a human monocytic cell line. J. Neurochem. 104 (2008) 524-533
42. Walsh D.M., Lomakin A., Benedek G.B., Condron M.M., and Teplow D.B. Amyloid β-protein fibrillogenesis: detection of a protofibrillar intermediate. J. Biol. Chem. 272 (1997) 22364-22372
43. Walsh D.M., Hartley D.M., Kusumoto Y., Fezoui Y., Condron M.M., Lomakin A., Benedek G.B., Selkoe D.J., and Teplow D.B. Amyloid β-protein fibrillogenesis: structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274 (1999) 25945-25952
44. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., and Selkoe D.J. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416 (2002) 535-539
45. Wegiel J., Imaki H., Wang K.C., and Rubenstein R. Cells of monocyte/microglial lineage are involved in both microvessel amyloidosis and fibrillar plaque formation in APPsw tg mice. Brain Res. 1022 (2004) 19-29
46. Williams A.D., Portelius E., Kheterpal I., Guo J.T., Cook K.D., Xu Y., and Wetzel R. Mapping Aβ amyloid fibril secondary structure using scanning proline mutagenesis. J. Mol. Biol. 335 (2004) 833-842
47. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., and Schmidt A.M. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382 (1996) 685-691